• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种针对酮症倾向型糖尿病的数学模型表明存在多种胰腺β细胞失活机制。

A mathematical model for ketosis-prone diabetes suggests the existence of multiple pancreatic β-cell inactivation mechanisms.

作者信息

Ridout Sean A, Vellanki Priyathama, Nemenman Ilya

机构信息

Department of Physics, Emory University, Atlanta, United States.

Initiative in Theory and Modeling of Living Systems, Emory University, Atlanta, United States.

出版信息

Elife. 2025 Jul 15;13:RP100193. doi: 10.7554/eLife.100193.

DOI:10.7554/eLife.100193
PMID:40662943
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12263149/
Abstract

Ketosis-prone diabetes mellitus (KPD) is a subtype of type 2 diabetes, which presents much like type 1 diabetes, with dramatic hyperglycemia and ketoacidosis. Although KPD patients are initially insulin-dependent, after a few months of insulin treatment, roughly 70% undergo near-normoglycemia remission and can maintain blood glucose without insulin, as in early type 2 diabetes or prediabetes. Here, we propose that these phenomena can be explained by the existence of a fast, reversible glucotoxicity process, which may exist in all people but be more pronounced in those susceptible to KPD. We develop a simple mathematical model of the pathogenesis of KPD, which incorporates this assumption, and show that it reproduces the phenomenology of KPD, including variations in the ability for patients to achieve and sustain remission. These results suggest that a variation of our model may be able to quantitatively describe variations in the course of remission among individuals with KPD.

摘要

酮症倾向型糖尿病(KPD)是2型糖尿病的一种亚型,其表现与1型糖尿病非常相似,伴有严重的高血糖和酮症酸中毒。虽然KPD患者最初依赖胰岛素,但经过几个月的胰岛素治疗后,大约70%的患者会出现近正常血糖缓解,并且可以像早期2型糖尿病或糖尿病前期患者一样,在不使用胰岛素的情况下维持血糖水平。在此,我们提出这些现象可以通过一种快速、可逆的糖毒性过程的存在来解释,这种过程可能存在于所有人中,但在易患KPD的人群中更为明显。我们建立了一个包含这一假设的KPD发病机制的简单数学模型,并表明它再现了KPD的现象学,包括患者实现和维持缓解能力的变化。这些结果表明,我们模型的一个变体可能能够定量描述KPD个体缓解过程中的变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36cd/12263149/9674c5136830/elife-100193-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36cd/12263149/c18b409d8bdd/elife-100193-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36cd/12263149/1d60e5c74a47/elife-100193-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36cd/12263149/1adb1811b138/elife-100193-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36cd/12263149/579293398a5d/elife-100193-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36cd/12263149/ae37a9e770d7/elife-100193-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36cd/12263149/e0146375489a/elife-100193-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36cd/12263149/9674c5136830/elife-100193-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36cd/12263149/c18b409d8bdd/elife-100193-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36cd/12263149/1d60e5c74a47/elife-100193-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36cd/12263149/1adb1811b138/elife-100193-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36cd/12263149/579293398a5d/elife-100193-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36cd/12263149/ae37a9e770d7/elife-100193-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36cd/12263149/e0146375489a/elife-100193-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36cd/12263149/9674c5136830/elife-100193-fig7.jpg

相似文献

1
A mathematical model for ketosis-prone diabetes suggests the existence of multiple pancreatic β-cell inactivation mechanisms.一种针对酮症倾向型糖尿病的数学模型表明存在多种胰腺β细胞失活机制。
Elife. 2025 Jul 15;13:RP100193. doi: 10.7554/eLife.100193.
2
A mathematical model for ketosis-prone diabetes suggests the existence of multiple pancreatic β-cell inactivation mechanisms.一种针对酮症倾向型糖尿病的数学模型表明存在多种胰腺β细胞失活机制。
bioRxiv. 2024 Jun 6:2024.06.04.597343. doi: 10.1101/2024.06.04.597343.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Type 1 Diabetes: A Guide to Autoimmune Mechanisms for Clinicians.1型糖尿病:临床医生自身免疫机制指南
Diabetes Obes Metab. 2025 May 15. doi: 10.1111/dom.16460.
5
Fatty acids and physical activity are critical for β-cell mass and insulin sensitivity: Pathways to T2D and prevention.脂肪酸和体育活动对β细胞量和胰岛素敏感性至关重要:2型糖尿病的发病途径及预防措施。
J Theor Biol. 2025 Aug 21;611:112188. doi: 10.1016/j.jtbi.2025.112188. Epub 2025 Jun 16.
6
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
7
The health economics of insulin therapy: How do we address the rising demands, costs, inequalities and barriers to achieving optimal outcomes.胰岛素治疗的卫生经济学:我们如何应对不断增长的需求、成本、不平等现象以及实现最佳治疗效果的障碍。
Diabetes Obes Metab. 2025 Jul;27 Suppl 5(Suppl 5):24-35. doi: 10.1111/dom.16488. Epub 2025 Jun 4.
8
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.1型糖尿病强化血糖控制与传统血糖控制的比较
Cochrane Database Syst Rev. 2014 Feb 14;2014(2):CD009122. doi: 10.1002/14651858.CD009122.pub2.
9
Glycaemic control in labour with diabetes: GILD, a scoping study.糖尿病产妇分娩期间的血糖控制:GILD,一项范围界定研究。
Health Technol Assess. 2025 Aug;29(41):1-150. doi: 10.3310/KHGD2761.
10
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.孕前糖尿病与妊娠:内分泌学会和欧洲内分泌学会联合临床实践指南
Eur J Endocrinol. 2025 Jun 30;193(1):G1-G48. doi: 10.1093/ejendo/lvaf116.

本文引用的文献

1
A Glycemic Threshold Above Which the Improvement of β-Cell Function and Glycemia in Response to Insulin Therapy Is Amplified in Early Type 2 Diabetes: The Reversal of Glucotoxicity.高血糖导致β细胞功能恶化及胰岛素抵抗,早期干预可能逆转这一过程
Diabetes Care. 2024 Nov 1;47(11):2017-2023. doi: 10.2337/dc24-1375.
2
Differential loss of β-cell function in youth vs. adults following treatment withdrawal in the Restoring Insulin Secretion (RISE) study.在“恢复胰岛素分泌(RISE)”研究中停止治疗后,年轻人和成年人β细胞功能的差异丧失。
Diabetes Res Clin Pract. 2021 Aug;178:108948. doi: 10.1016/j.diabres.2021.108948. Epub 2021 Jul 15.
3
Pancreatic β-cell heterogeneity in health and diabetes: classes, sources, and subtypes.
健康与糖尿病状态下胰腺β细胞的异质性:类别、来源及亚型
Am J Physiol Endocrinol Metab. 2021 Apr 1;320(4):E716-E731. doi: 10.1152/ajpendo.00649.2020. Epub 2021 Feb 15.
4
Array programming with NumPy.使用 NumPy 进行数组编程。
Nature. 2020 Sep;585(7825):357-362. doi: 10.1038/s41586-020-2649-2. Epub 2020 Sep 16.
5
Type 2 diabetes: one disease, many pathways.2 型糖尿病:一种疾病,多种途径。
Am J Physiol Endocrinol Metab. 2020 Aug 1;319(2):E410-E426. doi: 10.1152/ajpendo.00512.2019. Epub 2020 Jul 14.
6
Population insulin sensitivity from sparsely sampled oral glucose tolerance tests.从稀疏采样的口服葡萄糖耐量试验中评估人群胰岛素敏感性。
Metabolism. 2020 Sep;110:154298. doi: 10.1016/j.metabol.2020.154298. Epub 2020 Jun 20.
7
Long-term changes in carbohydrate tolerance, insulin secretion and action in African-American patients with obesity and history of hyperglycemic crises.非裔美国肥胖症患者伴有高血糖危象史者的糖耐受性、胰岛素分泌和作用的长期变化。
BMJ Open Diabetes Res Care. 2020 May;8(1). doi: 10.1136/bmjdrc-2019-001062.
8
A novel fast-slow model of diabetes progression: Insights into mechanisms of response to the interventions in the Diabetes Prevention Program.一种新的糖尿病进展的快慢模型:对糖尿病预防计划干预措施反应机制的深入了解。
PLoS One. 2019 Oct 10;14(10):e0222833. doi: 10.1371/journal.pone.0222833. eCollection 2019.
9
Long-term effects on glycaemic control and β-cell preservation of early intensive treatment in patients with newly diagnosed type 2 diabetes: A multicentre randomized trial.新诊断 2 型糖尿病患者早期强化治疗对血糖控制和β细胞保护的长期影响:一项多中心随机试验。
Diabetes Obes Metab. 2018 May;20(5):1121-1130. doi: 10.1111/dom.13196. Epub 2018 Jan 22.
10
DIABETIC KETOACIDOSIS: A COMMON DEBUT OF DIABETES AMONG AFRICAN AMERICANS WITH TYPE 2 DIABETES.糖尿病酮症酸中毒:2型糖尿病非裔美国人中糖尿病常见的首发症状
Endocr Pract. 2017 Aug;23(8):971-978. doi: 10.4158/EP161679.RA. Epub 2017 May 23.